Qvella

Resistell

This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.

Deepull

Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.

Novus Diagnostic

Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.

Anvil Diagnostics

This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.

Septest

This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.

iFAST Diagnositcs

The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.

CytoVale

This medical diagnostics company develops the IntelliSep test to provide rapid sepsis detection for hospital emergency departments and health systems.

Pattern Biosciences

This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.